Back
Ultragenyx Pharmaceutical Stock Price Chart
Invest in the Next Big AI Disruptor Today
Learn More
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.08 | Sell |
| 20-day SMA: | 56.96 | Sell |
| 50-day SMA: | 52.99 | Buy |
| 200-day SMA: | 46.88 | Buy |
| 8-day EMA: | 56.5 | Sell |
| 20-day EMA: | 56.46 | Sell |
| 50-day EMA: | 53.4 | Buy |
| 200-day EMA: | 47.32 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.8 | Buy |
| Relative Strength Index (14 RSI): | 43.18 | Sell |
| Chaikin Money Flow: | -435004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.76 - 58.26) | Sell |
| Bollinger Bands (100): | (40.14 - 54.08) | Buy |
Ultragenyx Pharmaceutical Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.43 while RARE 8-day simple moving average is 57.08, which is a Sell signal.
- The stock price of RARE is 54.43 while Ultragenyx Pharmaceutical 20-day SMA is 56.96, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 52.99 while RARE share price is 54.43, making it a Buy technically.
- RARE stock price is 54.43 and Ultragenyx Pharmaceutical 200-day simple moving average is 46.88, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
5.02B
Price in USD:
54.43
Share Volume:
575.01K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
31.52
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 54.43 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.43 while RARE 8-day exponential moving average is 56.50, which is a Sell signal.
- The stock price of RARE is 54.43 while Ultragenyx Pharmaceutical 20-day EMA is 56.46, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 53.40 while RARE share price is 54.43, making it a Buy technically.
- RARE stock price is 54.43 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.32, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is 0.8, suggesting Ultragenyx Pharmaceutical is a Buy
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 43.18, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (55.76 - 58.26), which suggest Ultragenyx Pharmaceutical is a Buy
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (40.14 - 54.08), which suggest Ultragenyx Pharmaceutical is a Buy
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.